Browse by author
Lookup NU author(s): Dr Feng Lin, Professor Stephen O'Brien
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Due to the lack of comparability of BCR-ABL mRNA quantification results generated by various methodologies in different laboratories, an international multicenter trial was started with the participation of six laboratories (platforms: LightCycler™, LC, n=3; TaqMan™, TM, n=3). One hundred and eighty-six PB samples derived from healthy donors were spiked with serial dilutions (1:20 to 1:2×106) of b2a2, b3a2 or e1a2 BCR-ABL positive white blood cells (WBC) from leukemic patients. After PAXgene™ stabilization, blinding, freezing and distribution, standardized RNA extraction, cDNA synthesis, PCR protocols and data evaluation were carried out. There was no significant difference in the results achieved using LC and TM technologies, but a considerable overall variation (CV=0.74 for ratios BCR-ABL/ABL). Up to a dilution of 1:1,000, 27/30 of the 2.5 mL samples tested positive. For higher dilutions, a PB volume of 5 or 10 ml was required to improve sensitivity. The study showed the feasibility of RQ-PCR standardization independent of the PCR machine used. ©2007 Ferrata Storti Foundation.
Author(s): Müller MC, Saglio G, Lin F, Pfeifer H, Press RD, Tubbs RR, Paschka P, Gottardi E, O'Brien SG, Ottmann OG, Stockinger H, Wieczorek L, Merx K, König H, Schwindel U, Hehlmann R, Hochhaus A
Publication type: Article
Publication status: Published
Journal: Haematologica
Year: 2007
Volume: 92
Issue: 7
Pages: 970-973
Print publication date: 01/07/2007
ISSN (print): 0390-6078
ISSN (electronic): 1592-8721
URL: http://dx.doi.org/10.3324/haematol.11172
DOI: 10.3324/haematol.11172
PubMed id: 17606448
Altmetrics provided by Altmetric
